Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride |
Is a |
Phenyl propanolamine hydrochloride (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride |
Is a |
Product containing codeine (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride |
Is a |
Product containing brompheniramine maleate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Substance with morphinan structure and opioid receptor agonist mechanism of action (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
maléate de bromphéniramine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Codeine phosphate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phenylpropanolamine hydrochloride |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Codeine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Central nervous system agent (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride |
Is a |
Codeine-containing product in oral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride |
Has manufactured dose form |
Oral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|